Vivos Therapeutics Stock Quote VVOS - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

2.715

Bid

2.70

Ask

2.73

Volume

65,507

2.52 Day's Range 2.74

2.40 52 Week Range 48.79

Market Cap

3.245M

Previous Close

2.77

Open

2.71

Last Trade

1000

2.715

Last Trade Time

14:39:46

Financial Volume

$ 173,299

VWAP

2.6455

Average Volume (3m)

227,443

Shares Outstanding

1,197,258

Dividend Yield

PE Ratio

-0.24

Earnings Per Share (EPS)

-11.35

Revenue

13.8M

Net Profit

-13.58M

Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral applian... Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for adult patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA). The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Vivos oral appliances have been used to treat over 15,000 patients worldwide by more than 1,100 trained dentists. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

vivos.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Vivos Therapeutics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker VVOS. The last closing price for Vivos Therapeutics was $2.77. Over the last year, Vivos Therapeutics shares have traded in a share price range of $ 2.40 to $ 48.79.

Vivos Therapeutics currently has 1,197,258 shares outstanding. The market capitalization of Vivos Therapeutics is $3.24 million. Vivos Therapeutics has a price to earnings ratio (PE ratio) of -0.24.

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

New Dentist Inquiries Jumped 600% andSigned Dentist Enrollment Contracts up 38% Sequentially Over Q3 CARE Oral Medical Device Unit Orders Increased 26% Following FDA Clearance LITTLETON, Colo...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.305	-10.0993377483	3.02	3.44	2.4	1170493	2.75082796	CS
4	-1.605	-37.1527777778	4.32	5.24	2.4	409518	2.96527322	CS
12	-4.275	-61.1587982833	6.99	9.1391	2.4	227443	4.16022897	CS
26	-5.485	-66.8902439024	8.2	48.79	2.4	669506	27.60428407	CS
52	-5.785	-68.0588235294	8.5	48.79	2.4	1926529	11.49999843	CS
156	-220.785	-98.7852348993	223.5	229.25	2.4	1378941	51.01571891	CS
260	-174.035	-98.4639321075	176.75	360.25	2.4	1282494	56.72095554	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WISAWiSA Technologies Inc	$ 5.74 (228.00%)	180.79M
JAGXJaguar Health Inc	$ 0.18 (51.52%)	552.77M
SXTCChina SXT Pharmaceuticals Inc	$ 1.69 (44.44%)	32.31M
ARRWArrowroot Acquisition Corporation	$ 17.50 (41.02%)	23.77k
MCBCMacatawa Bank Corporation	$ 13.715 (38.12%)	1.8M
PACBPacific Biosciences of California Inc	$ 1.5497 (-45.34%)	45.15M
KAVLKaival Brands Innovations Group Inc	$ 4.45 (-29.37%)	2.04M
RVYLRYVYL Inc	$ 1.47 (-28.68%)	864.4k
MDJHMDJM Ltd	$ 1.14 (-28.30%)	40.58k
SYTASiyata Mobile Inc	$ 2.40 (-27.71%)	74.03k
JAGXJaguar Health Inc	$ 0.18 (51.52%)	552.77M
WISAWiSA Technologies Inc	$ 5.74 (228.00%)	180.79M
SQQQProShares UltraPro Short QQQ	$ 11.401 (-0.34%)	149.52M
TSLATesla Inc	$ 156.32 (-3.20%)	81.86M
NKLANikola Corporation	$ 0.6711 (2.68%)	73.63M